Alnylam Pharmaceuticals shares owned by Capital Research Global Investors
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Capital Research Global Investors
from 13F filings
Historical chart of Capital Research Global Investors investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Capital Research Global Investors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Capital Research Global Investors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.3B | 7.2M | 455.99 |
| 2025-06-30 | $2.3B | 7.2M | 326.09 |
| 2025-03-31 | $1.9B | 7.2M | 270.02 |
| 2024-12-31 | $1.6B | 7.0M | 235.31 |
| 2024-09-30 | $1.4B | 5.2M | 275.03 |
| 2024-03-31 | $470M | 3.1M | 149.45 |
| 2023-12-31 | $561M | 2.9M | 191.42 |
| 2023-09-30 | $493M | 2.8M | 177.09 |
| 2023-06-30 | $447M | 2.4M | 189.94 |
| 2023-03-31 | $489M | 2.4M | 200.31 |
| 2022-12-31 | $198M | 832k | 237.65 |
More positions owned by Capital Research Global Investors
View all positions for Capital Research Global Investors